These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 161647)
1. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol]. Lussa A; Tymińska-Brzósko R Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647 [No Abstract] [Full Text] [Related]
2. Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE; Santoro SA; Sobel BE; Jaffe AS Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847 [TBL] [Abstract][Full Text] [Related]
3. Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma. Scully MF; Kakkar VV Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53894 [No Abstract] [Full Text] [Related]
4. [Effect of the enzyme preparation longolytin on fibrinolysis in animals]. Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406 [TBL] [Abstract][Full Text] [Related]
5. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood]. Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381 [TBL] [Abstract][Full Text] [Related]
6. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6. Kruithof EK; Mestries JC; Gascon MP; Ythier A Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O; Rijken DC; Collen D Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339 [TBL] [Abstract][Full Text] [Related]
8. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator]. Shimonaeva EE; Liutova LV; Andreenko GV Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779 [TBL] [Abstract][Full Text] [Related]
10. [Blood coagulating properties of immobilized proteases]. Zubairov DM; Zinkevich OD Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525 [TBL] [Abstract][Full Text] [Related]
12. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK). Lipinski B; Gurewich V; Hyde E Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799 [No Abstract] [Full Text] [Related]
13. [Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods]. Andreenko GV; Bessolitsyna LA; Sargin KE Kardiologiia; 1977 Jan; 17(1):98-103. PubMed ID: 140260 [TBL] [Abstract][Full Text] [Related]
14. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis. Thorsen S; Astrup T Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113 [No Abstract] [Full Text] [Related]
15. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Guimarães AH; Rijken DC Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222 [TBL] [Abstract][Full Text] [Related]
16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
17. [Fibrinolytic system in patients with nephrotic syndrome]. Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367 [No Abstract] [Full Text] [Related]
18. Effects of pro-urokinase and urokinase on the fibrinolytic system in man. Trübestein G; Popov S; Wolf H; Welzel D Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078 [TBL] [Abstract][Full Text] [Related]
19. [Determination of the enzyme activity of the fibrinolytic system using fibrinogen conjugated with peroxidase]. Liaginskiĭ AV; AfanasenkoGA ; Gudkova EV Lab Delo; 1991; (11):27-31. PubMed ID: 1722843 [TBL] [Abstract][Full Text] [Related]
20. In vitro effects of aspirin in fibrinolysis. Iatridis PG; Iatridis SG; Markidou SG; Ragatz BH Haemostasis; 1974; 3(1):55-64. PubMed ID: 4279872 [No Abstract] [Full Text] [Related] [Next] [New Search]